3E013GCIntroduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach

Administration›Physiological Systems and Anatomical Regions›Introduction
  • Billable / Specific Code
ICD-10-PCS 3E013GC
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

3E013GC is a billable ICD-10-PCS procedure code for Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Administration of therapeutic substances, NEC.

Code Identity

ICD-10-PCS Code
3E013GC
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach
Short Description
Introduction of Oth Therap Subst into Subcu, Perc Approach
Parent Code
3E0

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1Section3Administration
2Body SystemEPhysiological Systems and Anatomical Regions
3Operation0Introduction
4BodySystem/Region1Subcutaneous Tissue
5Approach3Percutaneous
6SubstanceGOther Therapeutic Substance
7QualifierCOther Substance

In the ICD-10-PCS Alphabetic Index

These FY 2027 ICD-10-PCS Alphabetic Index entries lead to this code:

IMFINZI(R)
Anatomy or device term that leads here
NexoBrid(tm)
Anatomy or device term that leads here
Defitelio
Anatomy or device term that leads here
TAVALISSE(R)
Anatomy or device term that leads here
Ruxolitinib
Anatomy or device term that leads here
Trilaciclib
Anatomy or device term that leads here
Fostamatinib
Anatomy or device term that leads here
Anacaulase-bcdb
Anatomy or device term that leads here
COSELA(tm) infusion
Anatomy or device term that leads here
SANTYL Ointment
Anatomy or device term that leads here
ENSPRYNG(tm) infusion
Anatomy or device term that leads here
Satralizumab-mwge
Anatomy or device term that leads here
TAVALISSE(R) infusion
Anatomy or device term that leads here
COSELA(tm) (Trilaciclib)
Anatomy or device term that leads here
JAKAFI(R) (Ruxolitinib)
Anatomy or device term that leads here

Browse the full ICD-10-PCS Alphabetic Index →

Clinical Classification (CCSR)

AHRQ groups this procedure code into these clinical categories.

ADM021
Administration of therapeutic substances, NEC
Clinical domain: Administration of Therapeutic Substances

Convert to ICD-9-PCS

Closest ICD-9-PCS equivalents for this code under the General Equivalence Mappings.

99.12
Immunization for allergy
Approximate match.
99.13
Immunization for autoimmune disease
Approximate match.
99.27
Iontophoresis
Approximate match.
99.29
Injection or infusion of other therapeutic or prophylactic substance
Approximate match.
99.75
Administration of neuroprotective agent
Approximate match.

Code History

Replaces previously assigned code(s):
  • XW01397 — Introduce Satralizum-mwge in Subcu, Perc, New Tech 7
Replaced in the FY 2027 code set by:
  • XW01318 — Introduce Daratumumab/Hyaluronid in Subcu, Perc, New Tech 8
  • XW0134C — Introduce Elamipretide in Subcu, Perc, New Tech 12
  • XW0136A — Introduce Dasiglucagon in Subcu, Perc, New Tech 10
  • XW01397 — Introduce Satralizum-mwge in Subcu, Perc, New Tech 7
  • XW013F5 — Introduce New Tech Therap in Subcu, Perc, New Tech 5
  • XW013TB — Introduce Rozanolixizumab in Subcu, Perc, New Tech 11
  • XW013W5 — Introduce Caplacizumab in Subcu, Perc, New Tech 5
  • XW01X27 — Introduce Anacaulase-bcdb in Subcu, Extern, New Tech 7

Similar Procedure Codes

Questions About 3E013GC

Is 3E013GC a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach on inpatient claims from October 1, 2026 through September 30, 2027.

What do the characters in 3E013GC mean?

The code breaks down character by character: the 1st character 3 is the Section (Administration); the 2nd character E is the Body System (Physiological Systems and Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 1 is the BodySystem/Region (Subcutaneous Tissue); the 5th character 3 is the Approach (Percutaneous); the 6th character G is the Substance (Other Therapeutic Substance); the 7th character C is the Qualifier (Other Substance).

What is the ICD-9-PCS equivalent of 3E013GC?

Under the General Equivalence Mappings, Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach crosswalks to ICD-9-PCS 99.12 (Immunization for allergy), 99.13 (Immunization for autoimmune disease), and 99.27 (Iontophoresis). The mapping is approximate, so confirm it fits the documentation.